Autobio Diagnostics Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Autobio Diagnostics Co., Ltd. carries a market capitalization of 17.79B, placing it among publicly traded companies globally. Its enterprise value stands at 20.88B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 17.79B |
| Enterprise Value | 20.88B |
Share Statistics
Autobio Diagnostics Co., Ltd. currently has 571.42M shares outstanding.
| Shares Outstanding | 571.42M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Autobio Diagnostics Co., Ltd. trades at a trailing price-to-earnings ratio of 18.79. The price-to-sales ratio is 4.98, and the price-to-book ratio stands at 4.48.
| PE Ratio | 18.79 |
| PS Ratio | 4.98 |
| PB Ratio | 4.48 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | 35.41 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Autobio Diagnostics Co., Ltd. trades at an EV/EBITDA multiple of 17.60 and an EV/FCF ratio of 33.31. The EV/Sales ratio of 4.83 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.60 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.83 |
| EV / EBITDA | 17.60 |
| EV / EBIT | 17.60 |
| EV / FCF | 33.31 |
Financial Position
Autobio Diagnostics Co., Ltd. maintains a current ratio of 2.34, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.66, indicating elevated leverage, while an interest coverage ratio of 58.81 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.34 |
| Quick Ratio | 0.35 |
| Debt / Equity | 1.66 |
| Debt / EBITDA | 0.12 |
| Interest Coverage | 58.81 |
Financial Efficiency
Autobio Diagnostics Co., Ltd. posts a return on equity of 24.91 and a return on invested capital of 12.44.
| Return on Equity (ROE) | 24.91 |
| Return on Assets (ROA) | 10.10 |
| Return on Invested Capital (ROIC) | 12.44 |
| Return on Capital Employed (ROCE) | 23.04 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.53 |
Taxes
Over the trailing twelve months, Autobio Diagnostics Co., Ltd. has paid 90.42M in income taxes, reflecting an effective tax rate of 7.29.
| Income Tax | 90.42M |
| Effective Tax Rate | 7.29 |
Stock Price Statistics
Autobio Diagnostics Co., Ltd.'s stock has declined approximately -17.88446% over the past 52 weeks. The 50-day moving average sits at 32.14, while the 200-day moving average is 35.44.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.88446% |
| 50-Day Moving Average | 32.14 |
| 200-Day Moving Average | 35.44 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Autobio Diagnostics Co., Ltd. generated 4.32B in revenue and converted that into 1.15B in net income, yielding earnings per share of 2.00. EBITDA reached 1.19B, while operating income came in at 1.19B.
| Revenue | 4.32B |
| Gross Profit | 2.81B |
| Operating Income | 1.19B |
| Pretax Income | 1.24B |
| Net Income | 1.15B |
| EBITDA | 1.19B |
| EBIT | 1.19B |
| Earnings Per Share (EPS) | 2.00 |
Balance Sheet
Autobio Diagnostics Co., Ltd. holds 888.13M in cash and equivalents against 142.23M in total debt, resulting in a net debt position of -363.31M. Total book value stands at 4.81B, with working capital of 3.40B providing operational flexibility.
| Cash & Cash Equivalents | 888.13M |
| Total Debt | 142.23M |
| Net Debt | -363.31M |
| Equity (Book Value) | 4.81B |
| Book Value Per Share | 8.37 |
| Working Capital | 3.40B |
Cash Flow
After subtracting -608.16M in capital expenditures, free cash flow totaled -608.16M - equivalent to -1.06 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -608.16M |
| Free Cash Flow | -608.16M |
| FCF Per Share | -1.06 |
Margins
Autobio Diagnostics Co., Ltd. operates with a gross margin of 64.97, reflecting its pricing power and cost economics. The operating margin of 27.43 and net profit margin of 26.50 provide insight into operational efficiency.
| Gross Margin | 64.97 |
| Operating Margin | 27.43 |
| Pretax Margin | 28.69 |
| Profit Margin | 26.50 |
| EBITDA Margin | 27.43 |
Dividends & Yields
The company's payout ratio of 63.41 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.27 |
| Dividend Yield | N/A |
| Payout Ratio | 63.41 |
| Shareholder Yield | 3.86 |
| FCF Yield | 2.82 |
Stock Splits
Autobio Diagnostics Co., Ltd.'s most recent stock split took place on May 27, 2021 with a 10:13 split ratio.
| Last Split Date | 5/27/2021 |
| Split Ratio | 10:13 |
Scores
Autobio Diagnostics Co., Ltd. posts an Altman Z-Score of 5.80, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.80 |